 Connection
Laura Dunn to Informed Consent
This is a "connection" page, showing publications Laura Dunn has written about Informed Consent.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.681 |
|
|
|
-
Marc-Aurele KL, Steinman SL, Ransom KM, Finer NN, Dunn LB. Evaluation of the content and process of informed consent discussions for neonatal research. J Empir Res Hum Res Ethics. 2012 Jul; 7(3):78-83.
Score: 0.385
-
Dunn LB, Misra S. Research ethics issues in geriatric psychiatry. Psychiatr Clin North Am. 2009 Jun; 32(2):395-411.
Score: 0.311
-
Dunn LB, Kim DS, Fellows IE, Palmer BW. Worth the risk? Relationship of incentives to risk and benefit perceptions and willingness to participate in schizophrenia research. Schizophr Bull. 2009 Jul; 35(4):730-7.
Score: 0.284
-
Dunn LB. Ethical issues in schizophrenia: considerations for treatment and research. Psychopharmacol Bull. 2007; 40(4):145-55.
Score: 0.263
-
Dunn LB. Capacity to consent to research in schizophrenia: the expanding evidence base. Behav Sci Law. 2006; 24(4):431-45.
Score: 0.245
-
Dunn LB, Palmer BW, Keehan M. Understanding of placebo controls among older people with schizophrenia. Schizophr Bull. 2006 Jan; 32(1):137-46.
Score: 0.241
-
Dunn LB, Gordon NE. Improving informed consent and enhancing recruitment for research by understanding economic behavior. JAMA. 2005 Feb 02; 293(5):609-12.
Score: 0.230
-
Dunn LB, Lindamer LA, Palmer BW, Golshan S, Schneiderman LJ, Jeste DV. Improving understanding of research consent in middle-aged and elderly patients with psychotic disorders. Am J Geriatr Psychiatry. 2002 Mar-Apr; 10(2):142-50.
Score: 0.188
-
Dunn LB, Lindamer LA, Palmer BW, Schneiderman LJ, Jeste DV. Enhancing comprehension of consent for research in older patients with psychosis: a randomized study of a novel consent procedure. Am J Psychiatry. 2001 Nov; 158(11):1911-3.
Score: 0.184
-
Dunn LB, Jeste DV. Enhancing informed consent for research and treatment. Neuropsychopharmacology. 2001 Jun; 24(6):595-607.
Score: 0.179
-
Palmer BW, Harmell AL, Dunn LB, Kim SY, Pinto LL, Golshan S, Jeste DV. Multimedia Aided Consent for Alzheimer's Disease Research. Clin Gerontol. 2018 Jan-Feb; 41(1):20-32.
Score: 0.140
-
Barrera AZ, Dunn LB, Nichols A, Reardon S, Mu?oz RF. Getting It "Right". J Empir Res Hum Res Ethics. 2016 10; 11(4):291-298.
Score: 0.129
-
Palmer BW, Harmell AL, Pinto LL, Dunn LB, Kim SY, Golshan S, Jeste DV. Determinants of Capacity to Consent to Research on Alzheimer's disease. Clin Gerontol. 2017; 40(1):24-34.
Score: 0.126
-
Bell E, Racine E, Chiasson P, Dufourcq-Brana M, Dunn LB, Fins JJ, Ford PJ, Glannon W, Lipsman N, Macdonald ME, Mathews DJ, McAndrews MP. Beyond consent in research. Revisiting vulnerability in deep brain stimulation for psychiatric disorders. Camb Q Healthc Ethics. 2014 Jul; 23(3):361-8.
Score: 0.110
-
Wildeman S, Dunn LB, Onyemelukwe C. Incapacity in Canada: review of laws and policies on research involving decisionally?impaired adults. Am J Geriatr Psychiatry. 2013 Apr; 21(4):314-25.
Score: 0.100
-
Palmer BW, Cassidy EL, Dunn LB, Spira AP, Sheikh JI. Effective use of consent forms and interactive questions in the consent process. IRB. 2008 Mar-Apr; 30(2):8-12.
Score: 0.071
-
Palmer BW, Dunn LB, Depp CA, Eyler LT, Jeste DV. Decisional capacity to consent to research among patients with bipolar disorder: comparison with schizophrenia patients and healthy subjects. J Clin Psychiatry. 2007 May; 68(5):689-96.
Score: 0.067
-
Mittal D, Palmer BW, Dunn LB, Landes R, Ghormley C, Beck C, Golshan S, Blevins D, Jeste DV. Comparison of two enhanced consent procedures for patients with mild Alzheimer disease or mild cognitive impairment. Am J Geriatr Psychiatry. 2007 Feb; 15(2):163-7.
Score: 0.066
-
Dunn LB, Palmer BW, Appelbaum PS, Saks ER, Aarons GA, Jeste DV. Prevalence and correlates of adequate performance on a measure of abilities related to decisional capacity: differences among three standards for the MacCAT-CR in patients with schizophrenia. Schizophr Res. 2007 Jan; 89(1-3):110-8.
Score: 0.065
-
Saks ER, Dunn LB, Palmer BW. Meta-consent in research on decisional capacity: a "Catch-22"? Schizophr Bull. 2006 Jan; 32(1):42-6.
Score: 0.061
-
Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005 Jul; 62(7):726-33.
Score: 0.059
-
Palmer BW, Dunn LB, Appelbaum PS, Jeste DV. Correlates of treatment-related decision-making capacity among middle-aged and older patients with schizophrenia. Arch Gen Psychiatry. 2004 Mar; 61(3):230-6.
Score: 0.054
-
Jeste DV, Dunn LB, Palmer BW, Saks E, Halpain M, Cook A, Appelbaum P, Schneiderman L. A collaborative model for research on decisional capacity and informed consent in older patients with schizophrenia: bioethics unit of a geriatric psychiatry intervention research center. Psychopharmacology (Berl). 2003 Dec; 171(1):68-74.
Score: 0.051
-
Saks ER, Dunn LB, Marshall BJ, Nayak GV, Golshan S, Jeste DV. The California Scale of Appreciation: a new instrument to measure the appreciation component of capacity to consent to research. Am J Geriatr Psychiatry. 2002 Mar-Apr; 10(2):166-74.
Score: 0.047
-
Appelbaum PS, Anatchkova M, Albert K, Dunn LB, Lidz CW. Therapeutic misconception in research subjects: development and validation of a measure. Clin Trials. 2012 Dec; 9(6):748-61.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|